Starpharma Holdings Limited Stock Other OTC
Equities
SPHRY
US8555631022
Pharmaceuticals
Sales 2022 | 5.16M 3.41M 4.66M | Sales 2023 | 4.21M 2.78M 3.8M | Capitalization | 127M 84.09M 115M |
---|---|---|---|---|---|
Net income 2022 | -16M -10.57M -14.46M | Net income 2023 | -15M -9.91M -13.55M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 27.57M 37.71M | Net cash position 2023 | 26.91M 17.78M 24.31M | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.68% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | 01-07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 23-04-02 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 22-03-31 |
Robert Thomas
CHM | Chairman | 79 | 13-12-03 |
David McIntyre
BRD | Director/Board Member | 53 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |